Clostridium Difficile (C. Difficile, C. Diff) is a bacterium that is found in the intestines. It most commonly causes mild to moderate diarrhea. Sometimes it can cause a more serious infection of the intestines, called colitis. In rare cases, infection with C. difficile can lead to death. C. difficile bacteria can be found in the intestines of healthy people. It is usually kept in check by other normal bacteria. When a person takes an antibiotic, some of the normal bacteria die and C. difficile bacteria can multiply. When C. difficile bacteria multiply, some are capable of producing toxins that cause diarrhea or inflammation of the colon.
Sanofi Pasteur and Albuquerque Clinical Trials are currently conducting a Phase III clinical trial to develop a vaccine to prevent C. diff. This vaccine could enable the body’s own defenses to directly target the cause of C diff disease. Vaccination could be an efficacious, cost-effective and important public health measure to protect vulnerable individuals from this devastating disease, in whome the attributable mortality is 8% – 15%.
If you are interested in learning more about this study, please go to our PARTICIPANT SIGN UP FORM and a member of our team will contact you to explain the options.
Watch KRQE Channel 13 News report on the C. Diff Study !